IL-8 enhances the angiogenic potential of human bone marrow mesenchymal stem cells by increasing vascular endothelial growth factor

Cell Biology International

Volumn 38, Issue 9, 2014, Pages 1050-1059

  Hou, Yun ^a   Ryu, Chung Heon ^b   Jun, Jin Ae ^a   Kim, Seong Muk ^b   Jeong, Chang Hyun ^a   Jeun, Sin Soo ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Angiogenesis; Interleukin 8; Mesenchymal stem cells; Stroke; Vascular endothelial growth factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; INTERLEUKIN 8; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; VASCULOTROPIN; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; FLAVONOID; MORPHOLINE DERIVATIVE; VASCULOTROPIN A;

AKT GENE; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CYTOKINE PRODUCTION; ERK GENE; GENE SILENCING; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PARACRINE SIGNALING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; ANIMAL; ANTAGONISTS AND INHIBITORS; BONE MARROW CELL; BRAIN; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; ISCHEMIA; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RAT;

ANIMALS; BONE MARROW CELLS; BRAIN; CELLS, CULTURED; CHROMONES; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HUMANS; INTERLEUKIN-8; ISCHEMIA; MESENCHYMAL STROMAL CELLS; MICE; MORPHOLINES; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84925883698     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10294     Document Type: Article

References (35)

1. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM ( 1986) Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17: 1304-8.
2. Chen JL, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu ZP, Chopp M ( 2003) Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92: 692-9.
3. Deng YB, Ye WB, Hu ZZ, Yan Y, Wang Y, Takon BF, Zhou GQ, Zhou YF ( 2010) Intravenously administered BMSCs reduce neuronal apoptosis and promote neuronal proliferation through the release of VEGF after stroke in rats. Neurol Res 32: 148-56.
4. Fresno Vara JÁ, Casado E, de Castro J, Cejas P, Belda-Iniesta C, González-Barón M ( 2004) PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193-204.
5. Glynn PC, Henney E, Hall IP ( 2002) The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-alpha-mediated inhibition of spontaneous neutrophil apoptosis. Pulm Pharmacol Therapeut 15: 103-10.
6. Grau AJ, Reis A, Buggle F, Al-Khalaf A, Werle E, Valois N, Bertram M, Becher H, Grond-Ginsbach C ( 2001) Monocyte function and plasma levels of interleukin-8 in acute ischemic stroke. J Neurol Sci 192: 41-7.
7. Herrmann JL, Weil BR, Abarbanell AM, Wang Y, Poynter JA, Manukyan MC, Meldrum DR ( 2011) IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms. Shock 35: 512-6.
8. Jain KK ( 2009) Cell therapy for CNS trauma. Mol Biotechnol 42: 367-76.
9. Knall C, Worthen GS, Johnson GL ( 1997) Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils in dependent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 94: 3052-7.
10. Kostulas N, Kivisäkk P, Huang Y, Matusevicius D, Kostulas V, Link H ( 1998) Ischemic stroke is associated with a systemic increase of blood mononuclear cells expressing interleukin-8 mRNA. Stoke 29: 462-6.
11. Kostulas N, Pelidou SH, Kivisäkk P, Kostulas V, Link H ( 1999) Increased IL-1beta, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stoke 30: 2174-9.
12. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H ( 2004) BDNF Gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9: 189-97.
13. Li A, Dubey S, Varney ML, Dave BJ, Singh RK ( 2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170: 3369-76.
14. Li M, Zhang Y, Feurino LW, Wang H, Fisher WE, Brunicardi FC, Chen C, Yao Q ( 2008) Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci 99: 733-7.
15. Lim JY, Jeong CH, Jun JA, Kim SM, Ryu CH, Hou Y, Oh W, Chang JW, Jeun SS ( 2011) Therapeutic effects of human umbilical cord blood-derived mesenchymal stem cells after intrathecal administration by lumbar puncture in a rat model of cerebral ischemia. Stem Cell Res Ther 2: 38.
16. Locatelli F, Bersano A, Ballabio E, Lanfranconi S, Papadimitriou D, Strazzer S, Bresolin N, Comi GP, Corti S ( 2009) Stem cell therapy in stroke. Cell Mol Life Sci 66: 757-72.
17. Longa EZ, Weinstein PR, Carlson S, Cummins R ( 1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91.
18. Luo Y, Wang Y, Poynter JA, Manukyan MC, Herrmann JL, Abarbanell AM, Weil BR, Meldrum DR ( 2012) Pretreating mesenchymal stem cells with interleukin-1β and transforming growth factor-β synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia. Surgery 151: 353-6.
19. Luppi F, Longo AM, de Boer WI, Rabe KF, Hiemstra PS ( 2007) Interleukin-8 stimulates cell proliferation in nonsmall cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56: 25-33.
20. Martin D, Galisteo R, Gutkind JS ( 2009) CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 284: 6038-42.
21. Muramatsu F, Kidoya H, Naito H, Sakimoto S, Takakura N ( 2013) MicroRNA-125b inhibits tube formation of blood vessels through translational suppression of VE-cadherin. Oncogene 32: 414-21.
22. Nickoloff BJ ( 1993) PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. Arch Dermatol 129: 250-1.
23. Patan S ( 2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117: 3-32.
24. Perng DW, Yang M, Hiao YH, Lo T, Lee OK, Wu MT, Wu YC, Lee YC ( 2012) MiRNA-146a expression positively regulates tumor necrosis factor-α-induced interleukin-8 production in mesenchymal stem cells and differentiated lung epithelial-like cells. Tissue Eng Part A 18: 2259-67.
25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti W, Craig S, Marshak DR ( 1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-7.
26. Ponce ML ( 2009) Tube formation: an in vitro matrigel angiogenesis assay. Methods Mol Biol 467: 183-8.
27. Quertainmont R, Cantinieaux D, Botman O, Sid S, Schoenen J, Franzen R ( 2012) Mesenchymal stem cell graft improves recovery after spinal cord injury in adult rats through neurotrophic and pro-angiogenic actions. PLoS One 7: e39500.
28. Richardson RM, Ali H, Pridgeon BC, Haribabu B, Snyderman R ( 1998) Multiple signaling pathways of human interleukin-8 receptor A independent regulation by phosphorylation. J Biol Chem 273: 10690-5.
29. Torrente Y, Polli E ( 2008) Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 17: 1103-1.
30. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR ( 2006) Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol-Regul Integr Comp Physiol 291: R880-4.
31. Wang Y, Crisostomo PR, Wang M, Markel TA, Novotny NM, Meldrum DR ( 2008) TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms. Am J Physiol-Regul Integr Comp Physiol 295: R1115-23.
32. Waugh DJ, Wilson C ( 2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14: 6735-41.
33. Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, Lin J, Yu J, Zhou X, Hu J ( 2007) Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 107: 17-29.
34. Yew TL, Hung YT, Li HY, Chen HW, Chen LL, Tsai KS, Chiou SH, Chao KC, Huang TF, Chen HL, Hung SC ( 2011) Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant 20: 693-706.
35. Zacharek A, Chen J, Cui X, Li A, Li Y, Roberts C, Feng Y, Gao Q, Chopp M ( 2007) Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke. J Cerebr Blood Flow Metabol 27: 1684-91.